FDA Inspection
BCN Peptides SABCN Peptides SA – FDA Inspection, Mar 15, 2019
Record Details
This FDA Inspection record concerns BCN Peptides SA, with an inspection on March 15, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
- Person
- MRA DavisM (Issuing Officer)
View Company Profile
ID · e9376b15-28bf-41c5-9574-806490d1bc08
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1112160
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of BCN Peptides SA
5| Date | Classification | Office | Project area |
|---|---|---|---|
| October 9, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 18, 2019 | NAI | Center for Veterinary Medicine | Pre-Approval Eval. of Animal Drugs and Food Additives |
| January 16, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 26, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 18, 2010 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for BCN Peptides SA
- FDA Inspection 1287710 - 2023-10-09
- FDA Inspection 1110777 - 2019-10-18
- FDA Inspection 917366 - 2015-01-16
- FDA Inspection 787875 - 2012-04-26
- FDA Inspection 659207 - 2010-03-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.